1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Europe Genomic Cancer Panel and Profiling Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Growing awareness of the benefits of genomic testing
3.2.1.2. Increasing demand for personalized medicine
3.2.1.3. Favorable government policies to support the development of genomic medicine
3.2.2. Restraints
3.2.2.1. High costs associated with genomic testing
3.2.2.2. Increasing concerns about data privacy and security
3.2.2.3. Lack of standardized guidelines
3.2.3. Opportunities
3.2.3.1. Advancements in technology
3.2.3.2. Expanding applications of genomic testing in various cancer types and stages
3.2.3.3. Integration with electronic health records
3.2.4. Challenges
3.2.4.1. Securing reimbursement for genomic testing
3.2.4.2. Addressing ethical concerns related to genomic testing
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Europe Genomic Cancer Panel and Profiling Market: Marketing Strategies
5. Europe Genomic Cancer Panel and Profiling Market: Pricing Analysis
6. Europe Genomic Cancer Panel and Profiling Market Overview
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Billion)
6.2. Market Share and Forecast
6.2.1. By Technology
6.2.1.1. Next-Generation Sequencing (NGS)
6.2.1.2. Polymerase Chain Reaction (PCR)
6.2.1.3. Fluorescence In-Situ Hybridization (FISH)
6.2.1.4. Immunohistochemistry (IHC)
6.2.1.5. Others (CRISPR, Liquid Biopsy Technologies)
6.2.2. By Application
6.2.2.1. Clinical
6.2.2.2. Research
6.2.3. By End User
6.2.3.1. Hospitals
6.2.3.2. Clinical & Diagnostic Laboratories
6.2.3.3. Research & Academic Institutes
6.2.3.4. Others
6.2.4. By Region
6.2.4.1. Germany
6.2.4.2. United Kingdom
6.2.4.3. Italy
6.2.4.4. France
6.2.4.5. Spain
6.2.4.6. Belgium
6.2.4.7. Russia
6.2.4.8. The Netherlands
6.2.4.9. Rest of Europe
7. Germany Genomic Cancer Panel and Profiling Market
7.1. Market Size & Forecast, 2019-2030
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Application
7.2.3. By End User
8. United Kingdom Genomic Cancer Panel and Profiling Market
8.1. Market Size & Forecast, 2019-2030
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Application
8.2.3. By End User
9. Italy Genomic Cancer Panel and Profiling Market
9.1. Market Size & Forecast, 2019-2030
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Application
9.2.3. By End User
10. France Genomic Cancer Panel and Profiling Market
10.1. Market Size & Forecast, 2019-2030
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Application
10.2.3. By End User
11. Spain Genomic Cancer Panel and Profiling Market
11.1. Market Size & Forecast, 2019-2030
11.1.1. By Value (USD Billion)
11.2. Market Share & Forecast
11.2.1. By Technology
11.2.2. By Application
11.2.3. By End User
12. Belgium Genomic Cancer Panel and Profiling Market
12.1. Market Size & Forecast, 2019-2030
12.1.1. By Value (USD Billion)
12.2. Market Share & Forecast
12.2.1. By Technology
12.2.2. By Application
12.2.3. By End User
13. Russia Genomic Cancer Panel and Profiling Market
13.1. Market Size & Forecast, 2019-2030
13.1.1. By Value (USD Billion)
13.2. Market Share & Forecast
13.2.1. By Technology
13.2.2. By Application
13.2.3. By End User
14. The Netherlands Genomic Cancer Panel and Profiling Market
14.1. Market Size & Forecast, 2019-2030
14.1.1. By Value (USD Billion)
14.2. Market Share & Forecast
14.2.1. By Technology
14.2.2. By Application
14.2.3. By End User
15. Rest of Europe Genomic Cancer Panel and Profiling Market
15.1. Market Size & Forecast, 2019-2030
15.1.1. By Value (USD Billion)
15.2. Market Share & Forecast
15.2.1. By Technology
15.2.2. By Application
15.2.3. By End User
16. Competitive Landscape
16.1. List of Key Players and Their Offerings
16.2. Europe Genomic Cancer Panel and Profiling Market Share Analysis, 2023
16.3. Competitive Benchmarking, By Operating Parameters
16.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
17. Impact of Escalating Geopolitical Tensions on Europe Genomic Cancer Panel and Profiling Market
18. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
18.1. F. Hoffmann-La Roche Ltd
18.2. ARUP Laboratories
18.3. Agilent
18.4. Caris Life Sciences
18.5. Thermo Fisher Scientific
18.6. Danher Corporation
18.7. Exact Sciences
18.8. EUCOPE
18.9. Guardant Health
18.10. Illumina
18.11. Merck & Co., Inc.
18.12. Novartis
18.13. Other Prominent Players
19. Key Strategic Recommendations
20. Research Methodology
20.1. Qualitative Research
20.1.1. Primary & Secondary Research
20.2. Quantitative Research
20.3. Market Breakdown & Data Triangulation
20.3.1. Secondary Research
20.3.2. Primary Research
20.4. Breakdown of Primary Research Respondents, By Country
20.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable